QED International Associates Announces Changes to the HealthShares(TM) GI/Gender Health Index
...trading on Friday February 29, 2008, UCB SA (Brussels: UCB.BR) will replace axcan Pharma, Inc. (Nasdaq (GS): AXCA) in the HealthShares(TM) GI/Gender Health Index. axcan Pharma is being acquired by an affiliate of TPG Capital, a leading private ...NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
SOPHIA ANTIPOLIS, France, May 11, 2007 /PRNewswire-FirstCall/ -- NicOx S.A. (Eurolist: COX) today provided an update on the phase 2a study for NCX 1000, which is covered by its codevelopment agreement with Axcan Pharma Inc. A preliminary analysis of 11 patients from this proof-of-concept study in...Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
...s -- Euro 0.3 million corresponding to the allocation of the remaining balance of the US$2 million license and option payments received from axcan following the termination of the development of NCX 1000 in May 2007 The initial March 2006 payments from Pfizer and Merck listed above were def...Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons
...l in Philadelphia, Pa. The event is sponsored by axcan Pharma (Nasdaq: AXCA ; TSX: AXP), Cardica, Inc. (...og on to http://www.ctsurgeon-event.com . About axcan Pharma axcan Pharma is a leading multinational specialty pharma...Take off: Canadian biotech industry thrives
...2004 versus $1.1 billion in 2003. Some of Canadas leading biotech companies include: Bioavail ID Biomedical Angiotech Pharmaceuticals QLT axcan Pharma Vasogen Canadian biotech companies have at least two stock exchanges on which to list: The Toronto Stock Exchange The Vancouver Stock ...